Investor Relations
Overview
Founded in 2007, Burjeel Holdings is one of the leading regional private healthcare service providers in the UAE and MENA, operating as an integrated network across primary, secondary, tertiary and quaternary care.
With a network of 39 hospitals and medical centres, we are the UAE market leader for in-patient market share, number of beds and number of doctors employed.
Our integrated healthcare network serves patients in Abu Dhabi, Al Ain, Dubai & the Northern Emirates in the UAE, as well as Oman, across all healthcare segments, and covers the full socio-economic spectrum through our five leading brands.
Investment
Highlights
Burjeel Holdings provides a comprehensive healthcare ecosystem to patients across the full socio-economic spectrum under the Burjeel, Medeor, LLH, Lifecare and Tajmeel brands, each of which is positioned to serve a different target demographic.
- The Group focuses on attracting, training and developing the best and most innovative consultants to drive medical advancements in the MENA region, through a unique culture of “physician-led” practices.
- The Group’s strong clinical team has been responsible for the Group’s growth to date and remains committed to delivering quality and clinical excellence going forward.
- The Group has been developing highly specialised, complex and personalised services in oncology, orthopaedics and spine, woman care and paediatrics.
- The UAE and Oman healthcare markets benefit from strong fundamentals and growth drivers which support the Group’s expansion.
- The UAE and Oman increased their healthcare expenditure from U.S.$12.4 billion and U.S.$2.9 billion, respectively, in 2016, to U.S.$18.0 billion and U.S.$3.5 billion, respectively, in 2021. They are expected to further expand healthcare investments to U.S.$34.0 billion and U.S.$5.3 billion, respectively, by 2031.
- The Group has a private market leading position in the UAE in terms of volumes, with a total bed capacity of 1,660 beds as at 30 June 2022 and 4.8 million out-patients and 104,965 in-patients treated across its hospital network in 2021, representing a UAE private market in-patient market share as at 30 June 2021 of approximately 17 per cent.
- The Group’s integrated healthcare network serves patients in Abu Dhabi, Al Ain, Dubai & the Northern Emirates in the UAE, as well as Oman, across all healthcare segments and covers the full socio-economic spectrum through the Group’s four leading brands.
- The Group has a strong and well-invested medical services portfolio that is built around an integrated “hub and spoke” feeder network across primary, secondary and tertiary segments.
- The Group has a track record of strong financial performance and consistent growth that has been driven by its ramp-up of assets launched in recent years and supported by its focus on treating a higher-end patient mix and cost optimisation.
- For the years ended 31 December 2019, 2020 and 2021, the Group’s revenue was AED 2,420.5 million, AED 2,605.2 million and AED 3,351.0 million, respectively, representing a CAGR of 17.7 per cent.
- For the years ended 31 December 2019, 2020 and 2021, the Group’s EBITDA was AED 417.9 million, AED 470.2 million and AED 779.1 million, respectively, representing a CAGR of 36.5 per cent.
Key Milestones in our Growth
2007
LLH Hospital, Abu Dhabi
Launched our multi-specialty hospital providing affordable care in Abu Dhabi.
2012
Burjeel Hospital, Abu Dhabi
Launched our quaternary care multi-specialty hospital in Abu Dhabi.
2013
Burjeel Hospital for Advanced Surgery, Dubai
Launched our advanced microsurgery and orthopedic center, providing access to advanced care in the UAE.
2014
Lifecare Hospital, Musaffah
Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.
2016
Tajmeel Specialized Medical Center, Abu Dhabi
Launched our premier medical center offering dermatology, dental and pediatric services.
2018
Burjeel Royal Hospital, Al Ain
Launched our luxurious, state-of-the-art healthcare facility to provide the most advanced medical care.
2020
Burjeel Medical City, Abu Dhabi
Launched our world-class quaternary care hospital providing extensive medical services in a luxurious environment.
2022
Kypros Nicolaides Fetal Medicine & Therapy Center
Launched the first comprehensive fetal medicine center in the region for diagnosing and treating fetal disorders.
2022
IHC takes minority stake in Burjeel Holdings
Experienced Abu Dhabi healthcare investor International Holding Company acquired a 15% stake in Burjeel Holdings.
2008
LLH Hospital, Musaffah
Launched our multi-specialty hospital to provide affordable care in the industrial district of Musaffah, Abu Dhabi.
2012
Lifecare Hospital, Baniyas
Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.
2013
Tajmeel Kids Park Medical Center, Abu Dhabi
Launched our premier medical center to provide comprehensive medical care for children and adolescents.
2015
Medeor Hospital, Abu Dhabi & Dubai
Opened two multi-specialty hospitals offering affordable, quality healthcare in a friendly environment.
2017
Burjeel Day Surgery Center, Abu Dhabi
Launched our day surgery center designed to help patients get back to their lives quickly and comfortably.
2019
Burjeel Specialty Hospital, Sharjah
Launched our multi-specialty hospital to provide the highest level of care and comfort to the people of the Sharjah region.
2022
Burjeel Farha, Al Ain
Launched Burjeel Farha, a multi-specialty hospital in Al Ain, to provide the highest quality healthcare in the region.
2022
Announced Kingdom of Saudi Arabia expansion
Announced our MoU with the KSA Ministry of Investment and our intention to seek opportunities to invest up to USD $1.0 billion in KSA by 2030.
Key
Metrics
AED 3,351.0m
Revenue (FY21)
AED 779.1m
EBITDA (FY21)
AED 234.1m
Net Profit (FY21)
23
Medical Centers
17.7%
Revenue CAGR (19-21)
36.5%
EBITDA CAGR (19-21)
23.3%
EBITDA Margin (FY21)
16
Hospitals
AED 1,898.4m
Revenue (1H22)
AED 414.2m
EBITDA (1H22)
AED 152.9m
Net Profit (1H22)
4.8m
Out-patients treated in 2021
104,965
In-patients treated in 2021
17%
UAE In-Patient Market Share (30 June 2022)
1,660
Total bed count (30 June 2022)
Key Figures
View and compare our historical financial performance across a range of metrics.
Learn MoreResults & Reports
Find out more about Burjeel Holdings through our reports, presentations and results.
Learn MoreContact Us
For General Enquiries and Investor Media Contacts
Contact Us